Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 1 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
AXESSIMMO from Ganshoren, company number BE0700580718, closed financial year 2025 with a result of € -29,940 after tax. For that financial year AXESSIMMO recorded a gross margin of € -2,601 and equity of € 130,925. Compared with financial year 2024, the result moved from € -34,706 to € -29,940. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.
€ 130,925
▼ 19% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -29,940
▲ 14 % less loss than in 2024
Profit after tax over the fiscal year.
€ 2,857
▲ 244% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -46,775.
Debts at end 2025
€ 26,197
▼ 9% vs 2024
€ 2,864 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 30,918
▲ 121% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 39,725 | € 144,574 | € 3,797 | € -2,601 | ▼ € 6,397 |
| Profit after taxes | € -10,724 | € 87,345 | € -34,706 | € -29,940 | ▲ € 4,766 |
| Equity | € 108,226 | € 195,571 | € 160,865 | € 130,925 | ▼ 19% |
| Total debts | € 524,476 | € 306,038 | € 309,561 | € 323,916 | ▲ 5% |
| Cash | € 20,104 | € 13,443 | € 831 | € 2,857 | ▲ 244% |
| Land & buildings | € 612,499 | € 483,738 | € 461,923 | € 447,613 | ▼ 3% |
| Retained profit | € -69,474 | € 17,871 | € -16,835 | € -46,775 | ▼ € 29,940 |
| Bank debt | € 252,526 | € 28,616 | € 28,782 | € 26,197 | ▼ 9% |
| Balance sheet total | € 632,703 | € 501,610 | € 470,426 | € 454,841 | ▼ 3% |
Key figures of AXESSIMMO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to AXESSIMMO?
What happened at AXESSIMMO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 29,940. filed late Source: NBB ↗
- New establishment in Ganshoren. KBO
- Start of the company according to the CBE. KBO
In short
From € 10,724 loss in 2022 to € 29,940 loss in 2025.
Paid € 6,028 in corporate taxes since 2022.
Best year ever: 2023, with € 87,345 profit.
A new publication or filing at AXESSIMMO? We notify you, reason included.
Follow AXESSIMMODatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind AXESSIMMO is Marc Czarka. Marc Czarka is also behind EUROPHARMEDTECH and HEALTHCARE MARKET AUTHORIZATION AND ACCESS ASSOCIATES.
Directors
According to the 2025 annual accounts
Marc Czarka
Director
Also active at: EUROPHARMEDTECH, HEALTHCARE MARKET AUTHORIZATION AND ACCESS ASSOCIATES
Establishments
Establishment units
Physical locations of this company
Keizer Karellaan 400 box 7
1083 Ganshoren
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0700.580.718
- VAT number
- BE 0700.580.718
- Registered office
- Keizer Karellaan 400 bus 7, 1083 Ganshoren
- Names & denominations
- AXESSIMMO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 2 August 2018
- Peppol
- Active · Active since 6 Feb 2025